Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma
2019 · Molecular Therapy — Oncolytics · 163 citations
https://doi.org/10.1016/j.omto.2019.08.002
L
Lingyan Ping
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
2.3K
Citations
24
h-index
41
i10-index
Lingyan Ping is an academic researcher from Emory University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & Chronic Lymphocytic Leukemia Research. The author has an h-index of 24, co-authored 103 publications.
Papers by this author
worksITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
2019 · Cancer Cell International · 37 citations
https://doi.org/10.1186/s12935-019-0754-9
Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
2024 · Alzheimer s & Dementia · 37 citations
https://doi.org/10.1002/alz.14360
Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
2019 · Journal of Experimental & Clinical Cancer Research · 34 citations
https://doi.org/10.1186/s13046-019-1076-4
Clinical characterization and outcome of primary bone lymphoma: a retrospective study of 61 Chinese patients
2016 · Scientific Reports · 25 citations
https://doi.org/10.1038/srep28834
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
2018 · Journal of Hematology & Oncology · 24 citations
https://doi.org/10.1186/s13045-018-0584-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat